Despite recent therapeutic advances, metastatic castration-resistant prostate cancer
(mCRPC) remains lethal. Chimeric antigen receptor (CAR) T cell therapies have …

The types of urothelial carcinoma (UC) include urothelial bladder cancer and upper tract
urothelial carcinoma. Current diagnostic techniques cannot meet the needs of patients …

Simple Summary Upper tract urothelial carcinoma (UTUC) is a lethal cancer of the urinary
tract. Radical nephroureterectomy with bladder cuff excision is the gold standard for the …

Pancreatic ductal adenocarcinoma (PDAC) has a five-year survival rate of less than 10%
due to its late diagnosis, rapid metastasis, and chemotherapeutic resistance. For a small …

Background Chimeric antigen receptor (CAR)-T cells are approved for use in the treatment
of hematological malignancies. Axicabtagene ciloleucel (YESCARTA) and brexucabtagene …

Background Cancer becomes lethal as it spreads from the primary site to the rest of the
body. Circulating tumor cells (CTCs) are biomarkers of disease progression and have been …

Background EAU guidelines strongly recommend kidney sparing surgery (KSS) as the
primary treatment option for the low-risk UTUC patients. While there are few reports …

Simple Summary Metastatic colorectal cancer (mCRC) is typified by its tumor heterogeneity
and changing disease states, suggesting that personalized medicine approaches could be …

Background Lung cancer screening with low‐dose computed tomography (CT) scans
(LDCT) has reduced mortality for patients with high‐risk smoking histories, but it has …

Background To establish the pathological diagnosis of UTUC before treatment is profitable.
At present, the conventional pathological diagnostic methods have certain problems …